Status:

COMPLETED

Study of the Durability of Glycemic Control With Nateglinide

Lead Sponsor:

Ajou University School of Medicine

Collaborating Sponsors:

Korea University Guro Hospital

Hanyang University

Conditions:

Type 2 Diabetes Mellitus

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

This multi-center, randomized controlled study aims to evaluate the durability and efficacy of nateglinide therapy for long term glycemic control compared with glimepiride.

Detailed Description

Selected patients will be randomly assigned to receive nateglinide or glimepiride. Previous treatment with oral antidiabetic drugs (metformin, a-glucosidase inhibitor, nateglinide or sulfonylurea) wi...

Eligibility Criteria

Inclusion

  • type 2 diabetes mellitus
  • age\>=18years
  • no anti hyperglycemic agent for 3 months or low-dose oral hypoglycemic therapy
  • metformin≤1g/day, acarbose≤300mg/day, voglibose≤0.9mg/day, nateglinide≤270mg/day, gliclazide≤80mg/day, glimepiride≤2mg/day, glibenclamide≤5mg/day (nateglinide or sulfonylurea \<6months)
  • 5% ≤ HbA1c ≤ 8.5%
  • patients on no anti hyperglycemic agent for 3 months : HbA1c at screening
  • patients on oral hypoglycemic therapy in 3months : HbA1c after wash-out

Exclusion

  • attending other clinical trials in 3months
  • type I diabetes mellitus
  • taking systemic steroid in 1month or requiring steroid therapy during clinical trial
  • acute myocardial infarction in 6months
  • alcoholics, pituitary or adrenal insufficiency, severe ketosis, diabetic ketoacidosis
  • severe liver disease or AST, ALT ≥ 2.5 x ULN
  • renal insufficiency (serum creatinine \> 2.0mg/dl)
  • other severe diabetic complication
  • drug hypersensitivity history to nateglinide or sulfonylurea
  • pregnant or plan to become pregnant during the clinical trial, lactation

Key Trial Info

Start Date :

April 24 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 25 2014

Estimated Enrollment :

88 Patients enrolled

Trial Details

Trial ID

NCT00858013

Start Date

April 24 2009

End Date

June 25 2014

Last Update

May 16 2017

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Hanyang University Medical Center

Guri-si, Gyeonggi-do, South Korea

2

Myongji Hospital

Ilsan, Kyounggi, South Korea

3

Inha University Hospital

Incheon, South Korea

4

Hallym University Medical Center

Seoul, South Korea

Study of the Durability of Glycemic Control With Nateglinide | DecenTrialz